The ART-naïve status of our study cohort, together with stratification based on the interferon gamma release assay [IGRA; [28]], the clinical diagnosis of active TB and HIV-1 disease progression markers, permitted a robust and concurrent comparative analysis between co-infect groups for which few data exist [15,25]. The gene discussed is IFNG; the disease is tuberculosis.